Background Difference-in-differences is a method commonly used in population health research. It is based on assumptions that ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
When researchers conduct many statistical tests simultaneously, the chance of obtaining false positives increases. Traditional methods for multiple comparisons, such ...
Empirical investigation requires dealing with fundamental uncertainty. In experimental psychology, research questions are often addressed using Null Hypothesis Significance Testing (NHST), an approach ...
Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
Abstract: Anomaly detection in multi-type event sequences is a crucial and challenging problem with important applications in various domains, including cybersecurity, finance and healthcare. Temporal ...
The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say. Reading time 3 minutes Your blood might someday reveal much about the ...
In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...
Lee Zeldin, the E.P.A. administrator, revived a plan created during the first Trump administration to end the testing of chemicals on mammals. By Lisa Friedman The Environmental Protection Agency will ...
The Environmental Protection Agency has stopped estimating the dollar value of lives saved in the cost-benefit analyses for new pollution rules. Los Angeles smog in 1979. For decades, government ...
Plasma measures of phosphorylated tau217 (p-tau217) can accurately identify individuals in the preclinical stage of Alzheimer’s disease (AD), a new meta-analysis showed. The results are important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results